Idec Eyes Success
Troubles that made Idec drop its lead drug convinced it to take on manufacturing. From a stock price in June 1994 of $2.44 to a stock price of $24 in September 1996, whatever becomes of the products now coming through Idec's pipeline, the strategy that got it out of some bad times is worth a closer look.
You may also be interested in...
Many biotechs, facing crisis situations in the fall of 2002, opted for deals that kept them alive but hardly offered much hope for upside. But in the coming months, boards may need to be far more realistic about their long-term prospects and consider a full range of options, including liquidation, when assessing a company's future.
The IPO is expected to raise $166m to support R&D of new arrhythmia mapping and ablation technologies and expand commercial operations.